Prometheus Biosciences Competitors and Similar CompaniesClear all
Prometheus Biosciences's competitors and similar companies include Sysmex Inostics, Opko Health, MorphoSys and Diater.
 Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. |  Sysmex Inostics Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers. |  Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. |  MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. |  Diater Diater is a pharmaceutical company specializing in the field of allergy treatment with immunotherapy. | |
Founding Date | Founding Date 1995 | Founding Date 2008 | Founding Date 2007 | Founding Date 1992 | Founding Date 1999 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Hamburg, DE HQ Kobe, JP Baltimore, US | Locations Miami, US HQ Woburn, US | Locations Planegg, DE HQ Boston, US | Locations Barcelona, ES HQ |
Employees | Employees 9735% increase | Employees 65 | Employees 6,0967% increase | Employees 464 | Employees 1644% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) $6.8m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) €238.3m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $400.9m (FY, 2025) | Cost of goods €34.6m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $205.9m (FY, 2025) | Gross profit €205.5m (FY, 2023) | Gross profit N/A |
Net income | Net income ($141.8m) (FY, 2022) | Net income N/A | Net income ($225.7m) (FY, 2025) | Net income (€189.7m) (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 130m | Total funding raised N/A | Total funding raised $ 31m | Total funding raised $ 126m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Sysmex Inostics
HQ
Hamburg, DE
Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
View companyOpko Health
HQ
Miami, US
Employees
6,096↑ 7% increase
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View companyMorphoSys
HQ
Planegg, DE
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
View companyDiater
HQ
Barcelona, ES
Employees
164↑ 4% increase
Diater is a pharmaceutical company specializing in the field of allergy treatment with immunotherapy.
View company